APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nitric Oxide Therapy System

Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung

Selected research

Market Outlook & Growth Opportunities

Global Nitric Oxide Therapy System Market Outlook and Growth Opportunities 2026

1 January 2026191 pages

Choose your research edition.

Industry ResearchNitric Oxide Therapy System Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nitric Oxide Therapy System Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Nitric Oxide Therapy System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nitric Oxide Therapy System Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Nitric Oxide Therapy System Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung

Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.

This report provides an overview of the global Nitric Oxide Therapy System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Nitric Oxide Therapy System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nitric Oxide Therapy System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nitric Oxide Therapy System market.

Nitric Oxide Therapy System Segment by Company

Bellerophon Therapeutics

BOC Healthcare

Dan Hammer Health

EKU Elektronik GmbH

GeNO LLC

International Biomedical

SLE

Mallinckrodt Pharmaceuticals

Praxair,

Vapotherm

Linde Group

Nitric Oxide Therapy System Segment by Type

Protable System

Fixed System

Nitric Oxide Therapy System Segment by Application

Hospitals

Homecare Settings

Others

Nitric Oxide Therapy System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nitric Oxide Therapy System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nitric Oxide Therapy System key companies, revenue, market share, and recent developments.

3. To split the Nitric Oxide Therapy System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nitric Oxide Therapy System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nitric Oxide Therapy System significant trends, drivers, influence factors in global and regions.

6. To analyze Nitric Oxide Therapy System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitric Oxide Therapy System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nitric Oxide Therapy System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitric Oxide Therapy System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nitric Oxide Therapy System industry.

Chapter 3: Detailed analysis of Nitric Oxide Therapy System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nitric Oxide Therapy System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nitric Oxide Therapy System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nitric Oxide Therapy System Industry Trends Table 2. Nitric Oxide Therapy System Industry Drivers Table 3. Nitric Oxide Therapy System Industry Opportunities and Challenges Table 4. Nitric Oxide Therapy System Industry Restraints Table 5. Global Nitric Oxide Therapy System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nitric Oxide Therapy System Revenue Share by Company (2021-2026) Table 7. Global Nitric Oxide Therapy System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nitric Oxide Therapy System Key Company Manufacturing Base & Headquarters Table 9. Global Nitric Oxide Therapy System Company, Product Type & Application Table 10. Global Nitric Oxide Therapy System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nitric Oxide Therapy System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Protable System Table 15. Significant Companies of Fixed System Table 16. Global Nitric Oxide Therapy System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Nitric Oxide Therapy System Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Nitric Oxide Therapy System Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Nitric Oxide Therapy System Sales Value Share by Type (2021-2026) Table 20. Global Nitric Oxide Therapy System Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Homecare Settings Table 23. Significant Companies of Others Table 24. Global Nitric Oxide Therapy System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nitric Oxide Therapy System Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Nitric Oxide Therapy System Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Nitric Oxide Therapy System Sales Value Share by Application (2021-2026) Table 28. Global Nitric Oxide Therapy System Sales Value Share by Application (2027-2032) Table 29. Global Nitric Oxide Therapy System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Nitric Oxide Therapy System Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Nitric Oxide Therapy System Sales Value Share by Region (2021-2026) Table 32. Global Nitric Oxide Therapy System Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Nitric Oxide Therapy System Sales Value Share by Region (2027-2032) Table 34. Global Nitric Oxide Therapy System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nitric Oxide Therapy System Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Nitric Oxide Therapy System Sales Value Market Share by Country (2021-2026) Table 37. Global Nitric Oxide Therapy System Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Nitric Oxide Therapy System Sales Value Market Share by Country (2027-2032) Table 39. Bellerophon Therapeutics Company Information Table 40. Bellerophon Therapeutics Business Overview Table 41. Bellerophon Therapeutics Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Bellerophon Therapeutics Nitric Oxide Therapy System Product Portfolio Table 43. Bellerophon Therapeutics Recent Development Table 44. BOC Healthcare Company Information Table 45. BOC Healthcare Business Overview Table 46. BOC Healthcare Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. BOC Healthcare Nitric Oxide Therapy System Product Portfolio Table 48. BOC Healthcare Recent Development Table 49. Dan Hammer Health Company Information Table 50. Dan Hammer Health Business Overview Table 51. Dan Hammer Health Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Dan Hammer Health Nitric Oxide Therapy System Product Portfolio Table 53. Dan Hammer Health Recent Development Table 54. EKU Elektronik GmbH Company Information Table 55. EKU Elektronik GmbH Business Overview Table 56. EKU Elektronik GmbH Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. EKU Elektronik GmbH Nitric Oxide Therapy System Product Portfolio Table 58. EKU Elektronik GmbH Recent Development Table 59. GeNO LLC Company Information Table 60. GeNO LLC Business Overview Table 61. GeNO LLC Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. GeNO LLC Nitric Oxide Therapy System Product Portfolio Table 63. GeNO LLC Recent Development Table 64. International Biomedical Company Information Table 65. International Biomedical Business Overview Table 66. International Biomedical Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. International Biomedical Nitric Oxide Therapy System Product Portfolio Table 68. International Biomedical Recent Development Table 69. SLE Company Information Table 70. SLE Business Overview Table 71. SLE Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. SLE Nitric Oxide Therapy System Product Portfolio Table 73. SLE Recent Development Table 74. Mallinckrodt Pharmaceuticals Company Information Table 75. Mallinckrodt Pharmaceuticals Business Overview Table 76. Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Product Portfolio Table 78. Mallinckrodt Pharmaceuticals Recent Development Table 79. Praxair, Company Information Table 80. Praxair, Business Overview Table 81. Praxair, Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Praxair, Nitric Oxide Therapy System Product Portfolio Table 83. Praxair, Recent Development Table 84. Vapotherm Company Information Table 85. Vapotherm Business Overview Table 86. Vapotherm Nitric Oxide Therapy System Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Vapotherm Nitric Oxide Therapy System Product Portfolio Table 88. Vapotherm Recent Development Table 89. Linde Group Company Information Table 90. Linde Group Business Overview Table 91. Linde Group Nitric Oxide Therapy System Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Linde Group Nitric Oxide Therapy System Product Portfolio Table 93. Linde Group Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Nitric Oxide Therapy System Product Image Figure 2. Global Nitric Oxide Therapy System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nitric Oxide Therapy System Market Size (2021-2032) & (US$ Million) Figure 4. Global Nitric Oxide Therapy System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Protable System Image Figure 8. Fixed System Image Figure 9. Global Nitric Oxide Therapy System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Nitric Oxide Therapy System Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Nitric Oxide Therapy System Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Homecare Settings Image Figure 14. Others Image Figure 15. Global Nitric Oxide Therapy System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nitric Oxide Therapy System Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nitric Oxide Therapy System Sales Value Share by Application (2021-2032) Figure 18. Global Nitric Oxide Therapy System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Nitric Oxide Therapy System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Nitric Oxide Therapy System Sales Value (2021-2032) & (US$ Million) Figure 21. North America Nitric Oxide Therapy System Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Nitric Oxide Therapy System Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Nitric Oxide Therapy System Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Nitric Oxide Therapy System Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Nitric Oxide Therapy System Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Nitric Oxide Therapy System Sales Value (2021-2032) & (US$ Million) Figure 27. South America Nitric Oxide Therapy System Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Nitric Oxide Therapy System Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Nitric Oxide Therapy System Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Protable System
  • Fixed System
Applications
  • Hospitals
  • Homecare Settings
  • Others
Companies covered
  • Bellerophon Therapeutics
  • BOC Healthcare
  • Dan Hammer Health
  • EKU Elektronik GmbH
  • GeNO LLC
  • International Biomedical
  • SLE
  • Mallinckrodt Pharmaceuticals
  • Praxair,
  • Vapotherm
  • Linde Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nitric Oxide Therapy System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nitric Oxide Therapy System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nitric Oxide Therapy System Market Dynamics
  1. 2.1 Nitric Oxide Therapy System Industry Trends
  2. 2.2 Nitric Oxide Therapy System Industry Drivers
  3. 2.3 Nitric Oxide Therapy System Industry Opportunities and Challenges
  4. 2.4 Nitric Oxide Therapy System Industry Restraints
3 Nitric Oxide Therapy System Market by Company
  1. 3.1 Global Nitric Oxide Therapy System Company Revenue Ranking in 2025
  2. 3.2 Global Nitric Oxide Therapy System Revenue by Company (2021-2026)
  3. 3.3 Global Nitric Oxide Therapy System Company Ranking (2024-2026)
  4. 3.4 Global Nitric Oxide Therapy System Company Manufacturing Base and Headquarters
  5. 3.5 Global Nitric Oxide Therapy System Company Product Type and Application
  6. 3.6 Global Nitric Oxide Therapy System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nitric Oxide Therapy System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nitric Oxide Therapy System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nitric Oxide Therapy System Market by Type
  1. 4.1 Nitric Oxide Therapy System Type Introduction
  2. 4.1.1 Protable System
  3. 4.1.2 Fixed System
  4. 4.2 Global Nitric Oxide Therapy System Sales Value by Type
  5. 4.2.1 Global Nitric Oxide Therapy System Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nitric Oxide Therapy System Sales Value by Type (2021-2032)
  7. 4.2.3 Global Nitric Oxide Therapy System Sales Value Share by Type (2021-2032)
5 Nitric Oxide Therapy System Market by Application
  1. 5.1 Nitric Oxide Therapy System Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Homecare Settings
  4. 5.1.3 Others
  5. 5.2 Global Nitric Oxide Therapy System Sales Value by Application
  6. 5.2.1 Global Nitric Oxide Therapy System Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nitric Oxide Therapy System Sales Value by Application (2021-2032)
  8. 5.2.3 Global Nitric Oxide Therapy System Sales Value Share by Application (2021-2032)
6 Nitric Oxide Therapy System Regional Value Analysis
  1. 6.1 Global Nitric Oxide Therapy System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nitric Oxide Therapy System Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nitric Oxide Therapy System Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nitric Oxide Therapy System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nitric Oxide Therapy System Sales Value (2021-2032)
  7. 6.3.2 North America Nitric Oxide Therapy System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nitric Oxide Therapy System Sales Value (2021-2032)
  10. 6.4.2 Europe Nitric Oxide Therapy System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nitric Oxide Therapy System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nitric Oxide Therapy System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nitric Oxide Therapy System Sales Value (2021-2032)
  16. 6.6.2 South America Nitric Oxide Therapy System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nitric Oxide Therapy System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nitric Oxide Therapy System Sales Value Share by Country, 2025 VS 2032
7 Nitric Oxide Therapy System Country-level Value Analysis
  1. 7.1 Global Nitric Oxide Therapy System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nitric Oxide Therapy System Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nitric Oxide Therapy System Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nitric Oxide Therapy System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nitric Oxide Therapy System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nitric Oxide Therapy System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nitric Oxide Therapy System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bellerophon Therapeutics
  2. 8.1.1 Bellerophon Therapeutics Company Information
  3. 8.1.2 Bellerophon Therapeutics Business Overview
  4. 8.1.3 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bellerophon Therapeutics Nitric Oxide Therapy System Product Portfolio
  6. 8.1.5 Bellerophon Therapeutics Recent Developments
  7. 8.2 BOC Healthcare
  8. 8.2.1 BOC Healthcare Company Information
  9. 8.2.2 BOC Healthcare Business Overview
  10. 8.2.3 BOC Healthcare Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BOC Healthcare Nitric Oxide Therapy System Product Portfolio
  12. 8.2.5 BOC Healthcare Recent Developments
  13. 8.3 Dan Hammer Health
  14. 8.3.1 Dan Hammer Health Company Information
  15. 8.3.2 Dan Hammer Health Business Overview
  16. 8.3.3 Dan Hammer Health Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dan Hammer Health Nitric Oxide Therapy System Product Portfolio
  18. 8.3.5 Dan Hammer Health Recent Developments
  19. 8.4 EKU Elektronik GmbH
  20. 8.4.1 EKU Elektronik GmbH Company Information
  21. 8.4.2 EKU Elektronik GmbH Business Overview
  22. 8.4.3 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 EKU Elektronik GmbH Nitric Oxide Therapy System Product Portfolio
  24. 8.4.5 EKU Elektronik GmbH Recent Developments
  25. 8.5 GeNO LLC
  26. 8.5.1 GeNO LLC Company Information
  27. 8.5.2 GeNO LLC Business Overview
  28. 8.5.3 GeNO LLC Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GeNO LLC Nitric Oxide Therapy System Product Portfolio
  30. 8.5.5 GeNO LLC Recent Developments
  31. 8.6 International Biomedical
  32. 8.6.1 International Biomedical Company Information
  33. 8.6.2 International Biomedical Business Overview
  34. 8.6.3 International Biomedical Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 International Biomedical Nitric Oxide Therapy System Product Portfolio
  36. 8.6.5 International Biomedical Recent Developments
  37. 8.7 SLE
  38. 8.7.1 SLE Company Information
  39. 8.7.2 SLE Business Overview
  40. 8.7.3 SLE Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SLE Nitric Oxide Therapy System Product Portfolio
  42. 8.7.5 SLE Recent Developments
  43. 8.8 Mallinckrodt Pharmaceuticals
  44. 8.8.1 Mallinckrodt Pharmaceuticals Company Information
  45. 8.8.2 Mallinckrodt Pharmaceuticals Business Overview
  46. 8.8.3 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Product Portfolio
  48. 8.8.5 Mallinckrodt Pharmaceuticals Recent Developments
  49. 8.9 Praxair,
  50. 8.9.1 Praxair, Company Information
  51. 8.9.2 Praxair, Business Overview
  52. 8.9.3 Praxair, Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Praxair, Nitric Oxide Therapy System Product Portfolio
  54. 8.9.5 Praxair, Recent Developments
  55. 8.10 Vapotherm
  56. 8.10.1 Vapotherm Company Information
  57. 8.10.2 Vapotherm Business Overview
  58. 8.10.3 Vapotherm Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Vapotherm Nitric Oxide Therapy System Product Portfolio
  60. 8.10.5 Vapotherm Recent Developments
  61. 8.11 Linde Group
  62. 8.11.1 Linde Group Company Information
  63. 8.11.2 Linde Group Business Overview
  64. 8.11.3 Linde Group Nitric Oxide Therapy System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Linde Group Nitric Oxide Therapy System Product Portfolio
  66. 8.11.5 Linde Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst